nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Trovafloxacin—TOP2A—hematologic cancer	0.00363	0.182	CrCbGaD
Gemifloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.00275	0.138	CrCbGaD
Gemifloxacin—Pefloxacin—TOP2A—hematologic cancer	0.002	0.101	CrCbGaD
Gemifloxacin—Enoxacin—TOP2A—hematologic cancer	0.00188	0.0941	CrCbGaD
Gemifloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.00173	0.0866	CrCbGaD
Gemifloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.00142	0.0713	CrCbGaD
Gemifloxacin—Levofloxacin—TOP2A—hematologic cancer	0.00121	0.0609	CrCbGaD
Gemifloxacin—Ofloxacin—TOP2A—hematologic cancer	0.00121	0.0609	CrCbGaD
Gemifloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.00117	0.0588	CrCbGaD
Gemifloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000985	0.0494	CrCbGaD
Gemifloxacin—Gatifloxacin—ALB—hematologic cancer	0.000788	0.0395	CrCbGaD
Gemifloxacin—Sparfloxacin—ABCB1—hematologic cancer	0.000491	0.0246	CrCbGaD
Gemifloxacin—Levofloxacin—ABCB1—hematologic cancer	0.000345	0.0173	CrCbGaD
Gemifloxacin—Ciprofloxacin—ABCB1—hematologic cancer	0.000334	0.0167	CrCbGaD
Gemifloxacin—Haemoglobin—Doxorubicin—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Headache—Gemcitabine—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Nausea—Vincristine—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—hematologic cancer	0.000108	0.00011	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—hematologic cancer	0.000107	0.000109	CcSEcCtD
Gemifloxacin—Dyspepsia—Dexamethasone—hematologic cancer	0.000107	0.000109	CcSEcCtD
Gemifloxacin—Dyspepsia—Betamethasone—hematologic cancer	0.000107	0.000109	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Urticaria—Triamcinolone—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Body temperature increased—Triamcinolone—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisone—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Oedema—Prednisone—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—hematologic cancer	0.000106	0.000108	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—hematologic cancer	0.000105	0.000108	CcSEcCtD
Gemifloxacin—Decreased appetite—Dexamethasone—hematologic cancer	0.000105	0.000108	CcSEcCtD
Gemifloxacin—Decreased appetite—Betamethasone—hematologic cancer	0.000105	0.000108	CcSEcCtD
Gemifloxacin—Nausea—Irinotecan—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Nausea—Mitoxantrone—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Fatigue—Dexamethasone—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Fatigue—Betamethasone—hematologic cancer	0.000105	0.000107	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Shock—Prednisone—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Pain—Dexamethasone—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Pain—Betamethasone—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Nervous system disorder—Prednisone—hematologic cancer	0.000104	0.000106	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisone—hematologic cancer	0.000103	0.000105	CcSEcCtD
Gemifloxacin—Skin disorder—Prednisone—hematologic cancer	0.000103	0.000105	CcSEcCtD
Gemifloxacin—Nausea—Gemcitabine—hematologic cancer	0.000103	0.000105	CcSEcCtD
Gemifloxacin—Vomiting—Cisplatin—hematologic cancer	0.000102	0.000104	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisone—hematologic cancer	0.000102	0.000104	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—hematologic cancer	0.000102	0.000104	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—hematologic cancer	0.000102	0.000104	CcSEcCtD
Gemifloxacin—Rash—Cisplatin—hematologic cancer	0.000101	0.000104	CcSEcCtD
Gemifloxacin—Dermatitis—Cisplatin—hematologic cancer	0.000101	0.000103	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—hematologic cancer	0.000101	0.000103	CcSEcCtD
Gemifloxacin—Anorexia—Prednisone—hematologic cancer	0.000101	0.000103	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—hematologic cancer	0.000101	0.000103	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—hematologic cancer	0.0001	0.000102	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—hematologic cancer	9.99e-05	0.000102	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—hematologic cancer	9.99e-05	0.000102	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—hematologic cancer	9.98e-05	0.000102	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—hematologic cancer	9.93e-05	0.000101	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	9.92e-05	0.000101	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	9.92e-05	0.000101	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—hematologic cancer	9.91e-05	0.000101	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—hematologic cancer	9.83e-05	0.0001	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—hematologic cancer	9.79e-05	9.99e-05	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—hematologic cancer	9.76e-05	9.96e-05	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—hematologic cancer	9.75e-05	9.95e-05	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—hematologic cancer	9.73e-05	9.93e-05	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—hematologic cancer	9.72e-05	9.92e-05	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—hematologic cancer	9.72e-05	9.92e-05	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—hematologic cancer	9.7e-05	9.9e-05	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—hematologic cancer	9.68e-05	9.88e-05	CcSEcCtD
Gemifloxacin—Urticaria—Dexamethasone—hematologic cancer	9.64e-05	9.83e-05	CcSEcCtD
Gemifloxacin—Urticaria—Betamethasone—hematologic cancer	9.64e-05	9.83e-05	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	9.63e-05	9.82e-05	CcSEcCtD
Gemifloxacin—Dizziness—Prednisolone—hematologic cancer	9.61e-05	9.81e-05	CcSEcCtD
Gemifloxacin—Asthenia—Triamcinolone—hematologic cancer	9.59e-05	9.79e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Betamethasone—hematologic cancer	9.59e-05	9.79e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Betamethasone—hematologic cancer	9.59e-05	9.79e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Dexamethasone—hematologic cancer	9.59e-05	9.79e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Dexamethasone—hematologic cancer	9.59e-05	9.79e-05	CcSEcCtD
Gemifloxacin—Nausea—Cisplatin—hematologic cancer	9.56e-05	9.75e-05	CcSEcCtD
Gemifloxacin—Insomnia—Prednisone—hematologic cancer	9.56e-05	9.75e-05	CcSEcCtD
Gemifloxacin—Pruritus—Triamcinolone—hematologic cancer	9.46e-05	9.65e-05	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—hematologic cancer	9.43e-05	9.62e-05	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—hematologic cancer	9.37e-05	9.56e-05	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—hematologic cancer	9.36e-05	9.55e-05	CcSEcCtD
Gemifloxacin—Dyspepsia—Prednisone—hematologic cancer	9.3e-05	9.49e-05	CcSEcCtD
Gemifloxacin—Rash—Etoposide—hematologic cancer	9.29e-05	9.48e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—hematologic cancer	9.29e-05	9.47e-05	CcSEcCtD
Gemifloxacin—Headache—Etoposide—hematologic cancer	9.23e-05	9.42e-05	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—hematologic cancer	9.23e-05	9.42e-05	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—hematologic cancer	9.21e-05	9.4e-05	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—hematologic cancer	9.21e-05	9.4e-05	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—hematologic cancer	9.19e-05	9.38e-05	CcSEcCtD
Gemifloxacin—Decreased appetite—Prednisone—hematologic cancer	9.18e-05	9.37e-05	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—hematologic cancer	9.17e-05	9.36e-05	CcSEcCtD
Gemifloxacin—Rash—Prednisolone—hematologic cancer	9.17e-05	9.35e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisolone—hematologic cancer	9.16e-05	9.34e-05	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.15e-05	9.33e-05	CcSEcCtD
Gemifloxacin—Fatigue—Prednisone—hematologic cancer	9.11e-05	9.29e-05	CcSEcCtD
Gemifloxacin—Headache—Prednisolone—hematologic cancer	9.11e-05	9.29e-05	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—hematologic cancer	9.1e-05	9.28e-05	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—hematologic cancer	9.1e-05	9.28e-05	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—hematologic cancer	9.08e-05	9.26e-05	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—hematologic cancer	9.06e-05	9.25e-05	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—hematologic cancer	9.06e-05	9.25e-05	CcSEcCtD
Gemifloxacin—Constipation—Prednisone—hematologic cancer	9.03e-05	9.22e-05	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—hematologic cancer	9.01e-05	9.19e-05	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—hematologic cancer	8.95e-05	9.13e-05	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—hematologic cancer	8.9e-05	9.08e-05	CcSEcCtD
Gemifloxacin—Dizziness—Triamcinolone—hematologic cancer	8.84e-05	9.02e-05	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	8.83e-05	9.01e-05	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—hematologic cancer	8.76e-05	8.93e-05	CcSEcCtD
Gemifloxacin—Asthenia—Betamethasone—hematologic cancer	8.7e-05	8.88e-05	CcSEcCtD
Gemifloxacin—Asthenia—Dexamethasone—hematologic cancer	8.7e-05	8.88e-05	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—hematologic cancer	8.66e-05	8.83e-05	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—hematologic cancer	8.66e-05	8.83e-05	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	8.64e-05	8.82e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	8.64e-05	8.81e-05	CcSEcCtD
Gemifloxacin—Nausea—Prednisolone—hematologic cancer	8.64e-05	8.81e-05	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—hematologic cancer	8.62e-05	8.79e-05	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—hematologic cancer	8.62e-05	8.79e-05	CcSEcCtD
Gemifloxacin—Pruritus—Betamethasone—hematologic cancer	8.58e-05	8.76e-05	CcSEcCtD
Gemifloxacin—Pruritus—Dexamethasone—hematologic cancer	8.58e-05	8.76e-05	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—hematologic cancer	8.58e-05	8.75e-05	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	8.56e-05	8.73e-05	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	8.54e-05	8.71e-05	CcSEcCtD
Gemifloxacin—Vomiting—Triamcinolone—hematologic cancer	8.5e-05	8.67e-05	CcSEcCtD
Gemifloxacin—Rash—Triamcinolone—hematologic cancer	8.43e-05	8.6e-05	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—hematologic cancer	8.43e-05	8.6e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Triamcinolone—hematologic cancer	8.42e-05	8.59e-05	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—hematologic cancer	8.42e-05	8.59e-05	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—hematologic cancer	8.42e-05	8.59e-05	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—hematologic cancer	8.4e-05	8.57e-05	CcSEcCtD
Gemifloxacin—Urticaria—Prednisone—hematologic cancer	8.39e-05	8.56e-05	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—hematologic cancer	8.39e-05	8.56e-05	CcSEcCtD
Gemifloxacin—Headache—Triamcinolone—hematologic cancer	8.38e-05	8.55e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Prednisone—hematologic cancer	8.35e-05	8.52e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Prednisone—hematologic cancer	8.35e-05	8.52e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Dexamethasone—hematologic cancer	8.3e-05	8.47e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Betamethasone—hematologic cancer	8.3e-05	8.47e-05	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—hematologic cancer	8.28e-05	8.45e-05	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	8.26e-05	8.43e-05	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—hematologic cancer	8.26e-05	8.43e-05	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	8.23e-05	8.4e-05	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—hematologic cancer	8.13e-05	8.29e-05	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—hematologic cancer	8.1e-05	8.27e-05	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	8.09e-05	8.25e-05	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—hematologic cancer	8.06e-05	8.23e-05	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.04e-05	8.21e-05	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—hematologic cancer	8.03e-05	8.19e-05	CcSEcCtD
Gemifloxacin—Dizziness—Betamethasone—hematologic cancer	8.02e-05	8.19e-05	CcSEcCtD
Gemifloxacin—Dizziness—Dexamethasone—hematologic cancer	8.02e-05	8.19e-05	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	7.99e-05	8.15e-05	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—hematologic cancer	7.99e-05	8.15e-05	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—hematologic cancer	7.98e-05	8.14e-05	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—hematologic cancer	7.98e-05	8.14e-05	CcSEcCtD
Gemifloxacin—Nausea—Triamcinolone—hematologic cancer	7.94e-05	8.1e-05	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.92e-05	8.08e-05	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—hematologic cancer	7.88e-05	8.04e-05	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—hematologic cancer	7.87e-05	8.03e-05	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—hematologic cancer	7.85e-05	8.01e-05	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—hematologic cancer	7.8e-05	7.96e-05	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—hematologic cancer	7.77e-05	7.93e-05	CcSEcCtD
Gemifloxacin—Vomiting—Dexamethasone—hematologic cancer	7.71e-05	7.87e-05	CcSEcCtD
Gemifloxacin—Vomiting—Betamethasone—hematologic cancer	7.71e-05	7.87e-05	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—hematologic cancer	7.68e-05	7.83e-05	CcSEcCtD
Gemifloxacin—Rash—Dexamethasone—hematologic cancer	7.65e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Rash—Betamethasone—hematologic cancer	7.65e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	7.65e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—hematologic cancer	7.65e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Dexamethasone—hematologic cancer	7.64e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Betamethasone—hematologic cancer	7.64e-05	7.8e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—hematologic cancer	7.62e-05	7.78e-05	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—hematologic cancer	7.61e-05	7.77e-05	CcSEcCtD
Gemifloxacin—Headache—Dexamethasone—hematologic cancer	7.6e-05	7.75e-05	CcSEcCtD
Gemifloxacin—Headache—Betamethasone—hematologic cancer	7.6e-05	7.75e-05	CcSEcCtD
Gemifloxacin—Asthenia—Prednisone—hematologic cancer	7.58e-05	7.73e-05	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—hematologic cancer	7.55e-05	7.7e-05	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.53e-05	7.68e-05	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—hematologic cancer	7.52e-05	7.67e-05	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—hematologic cancer	7.5e-05	7.65e-05	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	7.49e-05	7.64e-05	CcSEcCtD
Gemifloxacin—Pruritus—Prednisone—hematologic cancer	7.47e-05	7.63e-05	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—hematologic cancer	7.47e-05	7.63e-05	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—hematologic cancer	7.46e-05	7.61e-05	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—hematologic cancer	7.43e-05	7.58e-05	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	7.39e-05	7.54e-05	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—hematologic cancer	7.37e-05	7.52e-05	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—hematologic cancer	7.35e-05	7.5e-05	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—hematologic cancer	7.29e-05	7.44e-05	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—hematologic cancer	7.27e-05	7.42e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Prednisone—hematologic cancer	7.23e-05	7.38e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	7.22e-05	7.37e-05	CcSEcCtD
Gemifloxacin—Nausea—Dexamethasone—hematologic cancer	7.21e-05	7.35e-05	CcSEcCtD
Gemifloxacin—Nausea—Betamethasone—hematologic cancer	7.21e-05	7.35e-05	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—hematologic cancer	7.18e-05	7.33e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.13e-05	7.28e-05	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—hematologic cancer	7.12e-05	7.27e-05	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—hematologic cancer	7.07e-05	7.21e-05	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—hematologic cancer	7.07e-05	7.21e-05	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—hematologic cancer	7.01e-05	7.16e-05	CcSEcCtD
Gemifloxacin—Dizziness—Prednisone—hematologic cancer	6.99e-05	7.13e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—hematologic cancer	6.98e-05	7.12e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—hematologic cancer	6.98e-05	7.12e-05	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.97e-05	7.11e-05	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—hematologic cancer	6.91e-05	7.06e-05	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—hematologic cancer	6.82e-05	6.95e-05	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—hematologic cancer	6.8e-05	6.93e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	6.76e-05	6.89e-05	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—hematologic cancer	6.73e-05	6.87e-05	CcSEcCtD
Gemifloxacin—Vomiting—Prednisone—hematologic cancer	6.72e-05	6.85e-05	CcSEcCtD
Gemifloxacin—Rash—Prednisone—hematologic cancer	6.66e-05	6.8e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisone—hematologic cancer	6.66e-05	6.79e-05	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—hematologic cancer	6.65e-05	6.78e-05	CcSEcCtD
Gemifloxacin—Headache—Prednisone—hematologic cancer	6.62e-05	6.75e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.6e-05	6.73e-05	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—hematologic cancer	6.59e-05	6.73e-05	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—hematologic cancer	6.56e-05	6.7e-05	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—hematologic cancer	6.54e-05	6.67e-05	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—hematologic cancer	6.54e-05	6.67e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—hematologic cancer	6.53e-05	6.66e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—hematologic cancer	6.53e-05	6.66e-05	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—hematologic cancer	6.33e-05	6.46e-05	CcSEcCtD
Gemifloxacin—Nausea—Prednisone—hematologic cancer	6.28e-05	6.4e-05	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.25e-05	6.38e-05	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—hematologic cancer	6.25e-05	6.37e-05	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—hematologic cancer	6.07e-05	6.2e-05	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—hematologic cancer	6.04e-05	6.17e-05	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—hematologic cancer	6.04e-05	6.17e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—hematologic cancer	6.04e-05	6.16e-05	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—hematologic cancer	5.93e-05	6.05e-05	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—hematologic cancer	5.85e-05	5.96e-05	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—hematologic cancer	5.84e-05	5.96e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—hematologic cancer	5.65e-05	5.77e-05	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—hematologic cancer	5.61e-05	5.73e-05	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—hematologic cancer	5.57e-05	5.68e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—hematologic cancer	5.56e-05	5.68e-05	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—hematologic cancer	5.53e-05	5.64e-05	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—hematologic cancer	5.49e-05	5.6e-05	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—hematologic cancer	5.46e-05	5.58e-05	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—hematologic cancer	5.41e-05	5.52e-05	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—hematologic cancer	5.25e-05	5.36e-05	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—hematologic cancer	5.24e-05	5.35e-05	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—hematologic cancer	5.23e-05	5.34e-05	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—hematologic cancer	5.21e-05	5.32e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—hematologic cancer	5.2e-05	5.31e-05	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—hematologic cancer	5.18e-05	5.28e-05	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—hematologic cancer	5.06e-05	5.16e-05	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—hematologic cancer	4.91e-05	5.01e-05	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—hematologic cancer	4.86e-05	4.96e-05	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—hematologic cancer	4.82e-05	4.92e-05	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—hematologic cancer	4.82e-05	4.91e-05	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—hematologic cancer	4.79e-05	4.89e-05	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—hematologic cancer	4.54e-05	4.63e-05	CcSEcCtD
